Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03614637 · ClinicalTrials.gov registry record
Cannabis Use and Epigenetic Alterations in Human Male Sperm Cells
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 42
- Enrollment target
NCT03614637 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 42 participants.
The verdict
NCT03614637 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
This is a follow-up project to a proof-of-concept study to determine if Cannabis use in male humans is associated with changes in deoxyribonucleic acid (DNA) methylation profile of sperm. This proposal will examine the epigenome of sperm from men actively using Cannabis before and after a period of Cannabis abstinence. The results will be compared to control non-users.
Interventions
- OTHER Cannabis use abstinence for 11 weeks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2017-11-07 |
| Est. Completion | 2020-03-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03614637
The ClinicalTrials.gov registry entry for NCT03614637 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabis use abstinence for 11 weeks is the first listed.
NCT03614637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03614637 about?
NCT03614637 is a clinical study titled "Cannabis Use and Epigenetic Alterations in Human Male Sperm Cells". This is a follow-up project to a proof-of-concept study to determine if Cannabis use in male humans is associated with changes in deoxyribonucleic acid (DNA) methylation profile of sperm. This proposal will examine the epigenome of sperm from men actively using Cannabis before and after a period of ...
What is the current status of trial NCT03614637?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2017-11-07. Estimated completion is 2020-03-16.
What interventions are being tested in trial NCT03614637?
The interventions under investigation include: Cannabis use abstinence for 11 weeks (OTHER).
Who is sponsoring clinical trial NCT03614637?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.